Details of the Drug Combinations | DrugMAP

General Information of This Drug (ID: DM3370M)

Drug Name

Cholestyramine DM3370M

Indication

Disease Entry	ICD 11	Status	REF
Diarrhea	ME05.1	Approved	[1]
Hypercholesterolaemia	5C80.0	Approved	[2]
Hyperlipidemia	5C80.Z	Approved	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Cholestyramine + Teriflunomide	DCROYX3	Teriflunomide	Renal Impairment	[3]
Cholestyramine + Teriflunomide	DCNEQCJ	Teriflunomide	Multiple Sclerosis	[4]
Cholestyramine + Leflunomide	DCGAOP1	Leflunomide	Smoldering Plasma Cell Myeloma	[5]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Cholestyramine FDA Label
3	ClinicalTrials.gov (NCT01239459) Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
4	ClinicalTrials.gov (NCT02046629) A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
5	ClinicalTrials.gov (NCT05014646) Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients